（Last updated : 2018-12-07 15:22:14）
  NOGI HIROKO
   Department   The Jikei University School of Medicine  ,
   Position   Professor
■ Journal
1. 　 EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer 2009/04
2. 　 Triple-negative breast cancer exhibits a favorable response to neoadjuvant chemotherapy independence of the expression of topoisomerase IIα. 2016/04
3. 　 Long-term follow-up of node-negative breast cancer patients evaluated via sentinel node biopsy after neoadjuvant chemotherapy. 2017/12
■ BooK
1. 　 Triple-negative breast cancer exhibits a favorable response to neoadjuvant chemotherapy independence of the expression of topoisomerase Ⅱα, Molecular and Clinical Oncology 2016/03/01
■ Business career
1. 2018/02～ Jikei University, School of Medicine Associate Professor
■ Present specialized field
General surgery and pediatric surgery 
■ Department laboratory expense researcher number
80256429